Richard Baldry
Stock Analyst at Roth Capital
(1.26)
# 3,743
Out of 5,157 analysts
76
Total ratings
35.38%
Success rate
-10.9%
Average return
Main Sectors:
Stocks Rated by Richard Baldry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Maintains: Buy | $32 → $18 | $6.67 | +169.87% | 6 | Mar 6, 2026 | |
| CRM Salesforce | Maintains: Buy | $395 → $325 | $194.13 | +67.41% | 6 | Feb 26, 2026 | |
| EGAN eGain | Reiterates: Buy | $20 | $9.40 | +112.77% | 6 | Feb 4, 2026 | |
| GLOO Gloo Holdings | Reiterates: Buy | $17 | $6.31 | +169.41% | 2 | Jan 20, 2026 | |
| RSSS Research Solutions | Reiterates: Buy | $5 | $2.30 | +117.39% | 4 | Nov 14, 2025 | |
| SSTI SoundThinking | Reiterates: Buy | $30 → $20 | $7.19 | +178.16% | 5 | Nov 13, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $15 | $8.01 | +87.27% | 7 | Apr 1, 2025 | |
| CCLD CareCloud | Reiterates: Neutral | $3.5 → $1.5 | $2.66 | -43.61% | 2 | Mar 14, 2025 | |
| NOTE FiscalNote Holdings | Maintains: Buy | $36 → $24 | $1.02 | +2,252.94% | 2 | Mar 14, 2025 | |
| FORA Forian | Reiterates: Buy | $5 | $2.09 | +139.81% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 → $35 | $5.88 | +495.24% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $44 | $18.24 | +141.23% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $67 | $16.78 | +299.28% | 7 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $4.21 | +351.31% | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $3 → $2.5 | $0.55 | +350.86% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $9.83 | +32.25% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $90 | $2.77 | +3,149.10% | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $9.25 | +170.27% | 2 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $3.38 | +136.69% | 3 | Jan 19, 2022 |
OptimizeRx
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $18
Current: $6.67
Upside: +169.87%
Salesforce
Feb 26, 2026
Maintains: Buy
Price Target: $395 → $325
Current: $194.13
Upside: +67.41%
eGain
Feb 4, 2026
Reiterates: Buy
Price Target: $20
Current: $9.40
Upside: +112.77%
Gloo Holdings
Jan 20, 2026
Reiterates: Buy
Price Target: $17
Current: $6.31
Upside: +169.41%
Research Solutions
Nov 14, 2025
Reiterates: Buy
Price Target: $5
Current: $2.30
Upside: +117.39%
SoundThinking
Nov 13, 2025
Reiterates: Buy
Price Target: $30 → $20
Current: $7.19
Upside: +178.16%
Cryoport
Apr 1, 2025
Reiterates: Buy
Price Target: $15
Current: $8.01
Upside: +87.27%
CareCloud
Mar 14, 2025
Reiterates: Neutral
Price Target: $3.5 → $1.5
Current: $2.66
Upside: -43.61%
FiscalNote Holdings
Mar 14, 2025
Maintains: Buy
Price Target: $36 → $24
Current: $1.02
Upside: +2,252.94%
Forian
Nov 14, 2024
Reiterates: Buy
Price Target: $5
Current: $2.09
Upside: +139.81%
Nov 8, 2024
Reiterates: Buy
Price Target: $25 → $35
Current: $5.88
Upside: +495.24%
Oct 1, 2024
Maintains: Buy
Price Target: $33 → $44
Current: $18.24
Upside: +141.23%
Aug 9, 2024
Maintains: Buy
Price Target: $90 → $67
Current: $16.78
Upside: +299.28%
May 15, 2024
Maintains: Buy
Price Target: $19
Current: $4.21
Upside: +351.31%
May 7, 2024
Reiterates: Sell
Price Target: $3 → $2.5
Current: $0.55
Upside: +350.86%
Sep 13, 2023
Reiterates: Buy
Price Target: $13
Current: $9.83
Upside: +32.25%
Aug 9, 2023
Upgrades: Buy
Price Target: $90
Current: $2.77
Upside: +3,149.10%
May 9, 2023
Maintains: Buy
Price Target: $23 → $25
Current: $9.25
Upside: +170.27%
Jan 19, 2022
Upgrades: Buy
Price Target: $8
Current: $3.38
Upside: +136.69%